This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
CICC Expands into DIFC to Strengthen Cross-Border Financial Cooperation
Jan 20, 2025 03:54 PM
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM
Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"
Jan 08, 2025 06:10 PM
How AI is Driving Globalization and Transformation in Emerging Industries? | Highlights
Jan 08, 2025 05:44 PM
How Can F&B and Retail Companies Effectively Replicate Local Success Models? | Highlights
Jan 08, 2025 05:09 PM